NCT00569569View on ClinicalTrials.gov

Retaane® in Age-Related Macular Degeneration

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

March 31, 2007

Conditions

Age Related Macular Degeneration

Interventions

DRUG

juxtascleral depot injection of Retaane

juxtascleral depot injection of Retaane

All Listed Sponsors

lead

Rudolf Foundation Clinic

OTHER

NCT00569569 - Retaane® in Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter